Recombinant VWF (Caplacizumab Biosimilar) 抗体
The Humanized 单克隆 anti-VWF (Caplacizumab Biosimilar) antibody is suitable to detect VWF (Caplacizumab Biosimilar) in samples from 人. It has been validated for ELISA 和 WB.
产品编号 ABIN7538061
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant VWF (Caplacizumab Biosimilar) 抗体 (ABIN7538061)
抗原
VWF (Caplacizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Humanized
克隆类型
单克隆
应用范围
ELISA, Western Blotting (WB)
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Caplacizumab Biosimilar - Anti-VWF A1 domain mAb - Research Grade
-
产品特性
- Antibody Type: VH-VH
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
纯度
- > 85%
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS buffer PH7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- VWF (Caplacizumab Biosimilar)
-
物质类
- Biosimilar
-
背景
- Caplacizumab is a humanized anti-von Willebrand factor (vWF) nanobody. Caplacizumab inhibits the vWF-mediated platelet adhesion and prevents further microthrombi formation. Caplacizumab can be used for the research of thrombotic thrombocytopenic purpura (TTP).
-
CAS-编号
- 915810-67-2
抗原
-
You are here:
